Abstract
To evaluate the safety and efficacy of therapy with etanercept and methotrexate (MTX) in patients with active rheumatoid arthritis (RA) and mild hepatitis C virus (HCV) infection.
| Lingua originale | Inglese |
|---|---|
| pagine (da-a) | 286-292 |
| Numero di pagine | 7 |
| Rivista | THE JOURNAL OF RHEUMATOLOGY |
| Volume | 41 |
| Numero di pubblicazione | 2 |
| DOI | |
| Stato di pubblicazione | Pubblicato - 2014 |
All Science Journal Classification (ASJC) codes
- Immunologia e Allergia
- Reumatologia
- Immunologia
Keywords
- Adult
- Aged
- Alanine Transaminase
- Antirheumatic Agents
- Arthritis
- Aspartate Aminotransferases
- Combination
- DISEASE ACTIVITY SCORE
- Drug Therapy
- Female
- GISEA
- HEALTH ASSESSMENT QUESTIONNAIRE
- Hepacivirus
- Hepatitis C
- Humans
- Immunoglobulin G
- Liver Function Tests
- Male
- Methotrexate
- Middle Aged
- Prospective Studies
- Receptors
- Rheumatoid
- Severity of Illness Index
- TNF-α INHIBITORS
- TRANSAMINASES
- Treatment Outcome
- Tumor Necrosis Factor
- Viral Load
- Virus Replication